ArticleMolecules (Basel, Switzerland)2025
The Fate of Contaminants of Emerging Concern in an Upflow Anaerobic Sludge Blanket Reactor Coupled with Constructed Wetlands for Decentralized Domestic Wastewater Treatment.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Removal of micropollutants using biological treatment systems remains a challenge, since conventional bioprocess systems require adaptations to provide more advanced treatment. An ambient temperature upflow anaerobic sludge blanket (UASB) reactor was employed, followed by a two-stage (saturated and unsaturated) vertical subsurface flow (VSSF) constructed wetland (CW) system, to treat domestic wastewater from a nearby settlement and investigate the occurrence and fate of 10 contaminants of emerging concern (CECs) in decentralized, non-conventional treatment systems. The integrated UASB-two-stage CW system achieved high performance regarding abatement of target CECs across all periods. Removal efficiencies ranged from 78% ± 21% (ketoprofen) to practically 100% (2-hydroxybenzothiazole). The pilot system was found to be robust performance-wise and provided enhanced treatment in comparison to a conventional wastewater treatment plant operating in parallel. Most of the target CECs were successfully treated by UASB, saturated and unsaturated CWs, while ibuprofen, bisphenol A and diclofenac were mostly removed in the unsaturated CW. Environmental risk assessment revealed that triclosan poses a significant ecological risk to algae during treated wastewater disposal into the aquatic environment. Additionally, cumulative risk quotient indicated that the potential for mixture toxicity should be carefully considered across all trophic levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.